Stockchase Opinions

Paul Harris, CFA Nutrien Ltd. NTR-T DON'T BUY Nov 26, 2024

Large cost advantage due to Canadian base in potash. Big issue is volatility in a cyclical stock because of pricing of potash and nitrogen, which fluctuates a lot. Supply/demand is out of balance all the time. Volatility outweighs the story. Supply coming on globally, especially with BHP.

$64.550

Stock price when the opinion was issued

agriculture
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

WAIT

Farming has not been great for investments so profits from fertilizer businesses are down. However the cycle could change. Don't buy today except if you want the dividend - wait for the turn which should allow it to run for a while.

BUY
Positively impacted by US tariffs.

Sounds counterintuitive, but WFG and trees are going to be beneficiaries. US still needs them, just going to pay higher prices.

GRT.UN is a good name. PKI works well here. Materials sector, with a name like NTR. 

There's even a part of the TSX that does well with a falling CAD, as earnings get amplified.

DON'T BUY

Does not own shares. Better options for commodity investors. Dividend is strong, but potash in abundance throughout the globe. Would prefer Teck Resources. 

TOP PICK

World's largest ag-crop nutrient business. Vertically integrated. Believes prices for its input commodities have bottomed, supported by high and rising cash-crop prices. Farmers have to replace nutrients in soil, which was delayed while prices were so high. Trades at book value. Bounced off lows, but still sees upside. In his dividend growers mandate. Yield is 4%.

(Analysts’ price target is $84.66)
TOP PICK

World's largest crop-nutrient business. Upstream production is vertically integrated with downstream retail. Gamechanger for him is that commodity price has bottomed for potash, nitrogen, and phosphate. Cash crop commodity prices are also slowly improving. 

Management changes. Operational changes to improve profitability. Trading at 1.1x book. Good luck tariffing potash, as the US produces only 5% of what it needs, importing 70% of requirements from Canada. Yield is 4.29%.

(Analysts’ price target is $84.66)
TOP PICK

Brand-new position for him. Seems to be breaking out of resistance after basing. Former peaks are resistance targets. Likes it as part of his commodity complex. Bought his first 2% because of the breakout. If it breaks down from resistance, he'll take one leg out. If it fails long-term support, he'll get totally out. Yield is 3.68%.

(Analysts’ price target is $86.54)
BUY

Added to his portfolio in January. Has a long way to climb back, though not necessarily to the peaks of 2022. Prices of its component commodities are rising, amidst the backdrop of slowly improving prices for major agricultural cash crops. Margins are improving in South America. 

Likes the chart, turned a corner last summer. Lots of upside. Discounted valuation. Prolifically buying back shares. Yield is ~3.7-3.8%, above its long-run average.

RISKY

Stock's come back on relief from tariffs. Globally, demand for agriculture and fertilizer continues. Well positioned. Be aware that this name will be choppy, as we're not out of the tariff woods yet. More of a speculative play.

BUY ON WEAKNESS

Seeking new West Coast terminal to export more potash. Prices are just starting to trend a bit higher, which means demand is starting to pick up and supply is going down. Long term, warmer temperatures will mean growing seasons will be more difficult, so fertilizer demand should continue to rise. Yield is 3%.

Understand that commodity prices are always volatile in the short term. Up 27% YTD, 15% over 5 years, but 10 years has been 6%, 15 years has been 10%. So total return over time should be 5-10%. He doesn't offer price targets. 

BUY

Definitely putting in a major low. Highlighting this quite frequently to clients over the last couple of months. His fundamental analyst is highlighting this as well. Broke the bigger multi-year downtrend from 2022. Lots of institutional buying. Its peer in the States, MOS, is showing the same pattern.